![](/img/cover-not-exists.png)
Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families
Yu, K. J., Hsu, W.-L., Pfeiffer, R. M., Chiang, C.-J., Wang, C.-P., Lou, P.-J., Cheng, Y.-J., Gravitt, P., Diehl, S. R., Goldstein, A. M., Chen, C.-J., Hildesheim, A.Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-1681
Date:
April, 2011
File:
PDF, 167 KB
english, 2011